Somatostatin analogues labeled with copper radioisotopes: current status
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Radioanalytical and Nuclear Chemistry"
DOI: 10.1007/s10967-017-5323-x
Abstract: Peptide receptor radionuclide therapy (PRRT) is a promising way to treat patients with inoperable tumors or metastatic neuroendocrine tumors. This therapeutic strategy is using radiolabeled peptides, which are capable of selective biding to receptors overexpressed… read more here.
Keywords: labeled copper; copper radioisotopes; current status; analogues labeled ... See more keywords